5 321
订阅者
+124 小时
+277 天
+9530 天
帖子存档
5 320
Efficacy and safety of time-restricted eating in metabolic dysfunction-associated steatotic liver disease.
PDF 👇
EASL 2025
5 320
+1
Highlight- Expert Perspective on Diagnosis and Management of MASH.
The Liver Meeting 2025
5 320
+4
Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance.
PDF 👇
The Liver Meeting 2025
5 320
Fluid Therapy in Acute Pancreatitis—Current Knowledge and Future Perspectives 2025
MDPI 2025
